Table 1.
Baseline characteristics of subjects who were randomized to receive treatment with either EE/CMA or EE/DRSP
EE/CMAa (n = 90) |
EE/DRSPa (n = 90) |
|
---|---|---|
Age (yrs) | 28.5 ± 6.99 | 27.2 ± 6.05 |
Height (cm) | 158.4 ± 5.79 | 158.2 ± 4.92 |
Weight (kg) | 56.5 ± 10.02 | 56.1 ± 8.19 |
BMI (kg/m2) | 22.5 ± 3.36 | 22.4 ± 3.25 |
Systolic BP (mmhg) | 112.1 ± 11.49 | 110.3 ± 11.39 |
Diastolic BP (mmhg) | 67.2 ± 9.76 | 67.0 ± 9.35 |
aContinuous variables are presented as mean ± S.D